Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. It is characterized by hallucinations, delusions, and disorganized thinking and behavior. Symptoms may include talking to oneself, hearing voices, paranoia, and poor emotional control. People with schizophrenia often experience difficulties with daily activities, including work, school, and relationships. The cause of schizophrenia is unknown, but it is thought to involve a combination of environmental and genetic factors. It is believed to be related to a disruption in how the brain processes dopamine, a neurotransmitter involved in understanding and interpreting reality. Schizophrenia is also linked to abnormalities in brain structure and function, which can be seen in brain imaging scans, such as MRI. Treatment for schizophrenia is focused on controlling symptoms and improving quality of life. Common medications used for treatment include antipsychotic drugs like clozapine, risperidone, and olanzapine. These help to reduce hallucinations, delusions, and other symptoms. Therapy can also be used to help people cope with the social, emotional, and cognitive challenges of their disorder. Additionally, it is important for individuals to take an active role in managing their symptoms and recovery. Schizophrenia can be a difficult disorder to manage and treatment can often involve a multidisciplinary approach. It is important to remember that people with schizophrenia can still lead meaningful and productive lives with the proper support and treatment.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Neurojourney: A free, digital, and multilingual anticipatory guidance tool for parents and clinicians caring for children with severe neurological impairment
Blyth Lord, Courageous Parents Network, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States